• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Consumer Cyclical·2483.T
Share

Honyaku Center Inc. Stocks

¥ 2260Last Updated 16.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

¥ 47.61M

¥ 2260
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Honyaku Center Inc., established in 1986 and based in Osaka, Japan, delivers a comprehensive suite of translation and linguistic services to clients globally. The company specializes in technical documents across diverse fields, including patent applications and related legal proceedings, as well as medical texts covering basic research, clinical development, regulatory submissions, and post-market surveillance. Their expertise also extends to financial and legal materials, such as corporate disclosures, transactional documents, and general finance, in addition to IT documentation and technical manuals. For industrial clients, they translate materials ranging from R&D, planning, and design specifications to production, quality assurance, implementation, maintenance records, and sales/marketing collateral, along with content for non-manufacturing sectors. Beyond core translation, Honyaku Center Inc. provides medical writing, grammar checks, transcription, staffing solutions, multilingual contact center operations, proofreading, back translation, and support for foreign patent applications. They also prepare drawings and offer digital content localization for computer games, e-learning platforms, and websites. Furthermore, the company assists individuals with visa-related documentation for marriage, work, residency, or study abroad, and offers desktop publishing (DTP), printing, general document services, e-book translation, and localization for marketing materials like pamphlets, catalogs, press releases, newsletters, and presentations. Honyaku Center Inc. serves a broad spectrum of industries, including automotive, mechanical, electronics, pharmaceuticals, legal, finance, research and development, and education.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'cheap' on EV

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

18.10.2026 21:01

Anthropic's Valuation Falls, SpaceX Drives the Market: Key Takeaways on IPOs as of October 18

17.10.2026 21:12

DeepSeek unveils updated AI model claimed to be faster than its predecessor

17.10.2026 16:01

Small caps last week: Russell 2000 correction, Bumble sale, Crocs celeb partnerships

17.10.2026 13:01

The Weak Link in the AI Revolution: Big Pharma Comes to the Rescue of Investors; Burry Believes in Mortgages

17.10.2026 03:47

‘All of this is going to pass’: Nvidia CEO is confident AI rally will continue

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026